JOHN DOCHERTY - 29 Aug 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
President, Director
Signature
/John Docherty/
Issuer symbol
LEXX
Transactions as of
29 Aug 2022
Net transactions value
$0
Form type
4
Filing time
29 Aug 2022, 17:26:10 UTC
Previous filing
02 Sep 2021
Next filing
30 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 54,075 29 Aug 2022 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +30,000 +46% $0.000000 94,668 29 Aug 2022 Common Shares 30,000 $2.91 Direct
holding LEXX Stock Options 13,334 29 Aug 2022 Common Shares 13,334 $9.60 Direct
holding LEXX Stock Options 31,334 29 Aug 2022 Common Shares 18,000 $5.31 Direct
holding LEXX Stock Options 49,668 29 Aug 2022 Common Shares 18,334 $7.08 Direct
holding LEXX Stock Options 64,668 29 Aug 2022 Common Shares 15,000 $6.23 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.